← Leaderboards
Harald Junge
University Of Minnesota
$5,205,817
Attributed
$6,354,535
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,354,535 · 3
By mechanism
R01$5,921,467 · 2
T32$433,068 · 1
Top collaborators
- Stephane Angers5 shared
- Linda K Mcloon3 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Stephane Angers$1,341,861
- Corinne L. Fairchild$259,685
Others in their field
Top investigators on “Retinal Diseases”
- John M Lachin · George Washington University$134,552,372
- David M Nathan · Massachusetts Institute Of Technology$124,992,303
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Rose A Gubitosi-Klug · Case Western Reserve University$63,023,244
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Martin Friedlander · Scripps Research Institute$49,113,861
Research focus
Retinal DiseasesRetinaPathway InteractionsMediatingDefectBlood VesselsEndothelial CellsSignal TransductionCellsProteinsPericytesIn VitroBeta CateninImpairmentFunctional DisorderRetinopathy Of PrematurityExtravasationFamilial Exudative VitreoretinopathyAgonistModalityMouse ModelBloodDiabetic RetinopathyDisease Model
Grant awards (18)
Investigation of a first-in-class Frizzled4/LRP5 agonist in retinal disease models$453,631
R01 · FY2025 · EY · contact PI
Investigation of a first-in-class Frizzled4/LRP5 agonist in retinal disease models$453,631
R01 · FY2024 · EY · contact PI
Training Program in Translational Vision Sciences$129,797
T32 · FY2024 · EY
Investigation of a first-in-class Frizzled4/LRP5 agonist in retinal disease models$36,094
R01 · FY2024 · EY · contact PI
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier$454,054
R01 · FY2023 · EY · contact PI
Investigation of a first-in-class Frizzled4/LRP5 agonist in retinal disease models$453,631
R01 · FY2023 · EY · contact PI
Training Program in Translational Vision Sciences$155,651
T32 · FY2023 · EY
Investigation of a first-in-class Frizzled4/LRP5 agonist in retinal disease models$467,381
R01 · FY2022 · EY · contact PI
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier$440,431
R01 · FY2022 · EY · contact PI
Training Program in Translational Vision Sciences$147,620
T32 · FY2022 · EY
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier$440,431
R01 · FY2021 · EY · contact PI
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier$451,370
R01 · FY2020 · EY · contact PI
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier$432,379
R01 · FY2019 · EY · contact PI
Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12$367,959
R01 · FY2018 · EY · contact PI
Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12$368,592
R01 · FY2017 · EY · contact PI
Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12$369,195
R01 · FY2016 · EY · contact PI
Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12$362,372
R01 · FY2015 · EY · contact PI
Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12$370,316
R01 · FY2014 · EY · contact PI